Chemoinformaics analysis of 2-(1,3-BENZODIOXOL-5-YL)-1-METHYLQUINOLIN-4-ONE
| Molecular Weight | 279.295 | nRot | 1 |
| Heavy Atom Molecular Weight | 266.191 | nRig | 0 |
| Exact Molecular Weight | 279.09 | nRing | 4 |
| Solubility: LogS | -4.166 | nHRing | 2 |
| Solubility: LogP | 4.228 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 17 |
| nHA | 4 | APOL | 40.5643 |
| nHD | 0 | BPOL | 19.0917 |
| QED | 0.476 |
| Synth | 1.261 |
| Natural Product Likeliness | 0.349 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.003 |
| CACO-2 | -4.239 |
| MDCK | 0.0000174 |
| BBB | 0.982 |
| PPB | 0.934941 |
| VDSS | 2.476 |
| FU | 0.0866487 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.774 |
| CYP2c19-inh | 0.491 |
| CYP2c19-sub | 0.783 |
| CYP2c9-inh | 0.341 |
| CYP2c9-sub | 0.862 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.173 |
| CYP3a4-inh | 0.041 |
| CYP3a4-sub | 0.135 |
| CL | 7.372 |
| T12 | 0.427 |
| hERG | 0.053 |
| Ames | 0.008 |
| ROA | 0.1 |
| SkinSen | 0.582 |
| Carcinogencity | 0.082 |
| EI | 0.984 |
| Respiratory | 0.51 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.826958 |